Decreased Microglial Activation Precedes Stabilization of Disability in Multiple Sclerosis Patients Treated with Natalizumab (S21.004)
Marios Politis(University of Exeter), Paola Piccini(Hammersmith Hospital), Richard Nicholas(Swansea University), Adam Waldman(Royal Society of Edinburgh), Richard Reynolds(Hammersmith Hospital), Federico Turkheimer(King's College London), Paul Su(Hammersmith Hospital), Flavia Niccolini(King's College London), Paolo Giannetti(Hammersmith Hospital)
Cited by 3
Related Papers
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
|The Lancet Oncology|2011|649
Priorities in Parkinson's disease research
|Nature Reviews Drug Discovery|2011|430
Fasting biases brain reward systems towards high‐calorie foods
|European Journal of Neuroscience|2009|355